A detailed history of Simplex Trading, LLC transactions in Biovie Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 2,793 shares of BIVI stock, worth $1,256. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,793
Previous 15,783 82.3%
Holding current value
$1,256
Previous $19,000 94.74%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$0.53 - $1.89 $6,884 - $24,551
-12,990 Reduced 82.3%
2,793 $1,000
Q4 2023

Feb 02, 2024

SELL
$1.22 - $5.24 $5,685 - $24,418
-4,660 Reduced 22.8%
15,783 $19,000
Q3 2023

Nov 01, 2023

BUY
$2.75 - $5.17 $28,902 - $54,336
10,510 Added 105.81%
20,443 $69,000
Q2 2023

Aug 04, 2023

BUY
$4.09 - $8.29 $40,625 - $82,344
9,933 New
9,933 $42,000

Others Institutions Holding BIVI

About BIOVIE INC.


  • Ticker BIVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,165,300
  • Market Cap $13.6M
  • Description
  • BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...
More about BIVI
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.